Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancer (Q33901988)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancer |
scientific article |
Statements
1 reference
Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancer (English)
1 reference
John D Hainsworth
1 reference
David R Spigel
1 reference
Howard A Burris
1 reference
F Anthony Greco
1 reference
Dianna L Shipley
1 reference
Elke K Friedman
1 reference
David M Waterhouse
1 reference
Robert C Whorf
1 reference
R Brian Mitchell
1 reference
Davey B Daniel
1 reference
Jeffrey Zangmeister
1 reference
J David Bass
1 reference
16 May 2011
1 reference
1 reference
29
1 reference
18
1 reference
2582-2589
1 reference
Identifiers
1 reference
1 reference